Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2000 | 12-1999 | 12-1998 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 3,298 | 138 | 2,730 |
| Receivables | 3,579 | 10,702 | 6,109 |
| Inventories | N/A | 2,071 | 1,625 |
| Other current assets | 3,194 | 3,107 | 455 |
| TOTAL | $10,072 | $16,018 | $10,918 |
| Non-Current Assets | |||
| PPE Net | 5,243 | 10,495 | 7,019 |
| Intangibles | 6,533 | 9,873 | 9,099 |
| Other Non-Current Assets | 3,728 | 1,174 | 780 |
| TOTAL | $15,504 | $21,542 | $16,897 |
| Total Assets | $25,576 | $37,561 | $27,816 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 3,668 | 7,388 | 1,430 |
| Accounts payable and accrued liabilities | 4,049 | 13,395 | 8,969 |
| Other current liabilities | 2,132 | 138 | 780 |
| TOTAL | $9,849 | $20,921 | $11,178 |
| Non-Current Liabilities | |||
| Long Term Debt | 3,250 | 2,417 | 6,564 |
| TOTAL | $3,250 | $2,417 | $6,629 |
| Total Liabilities | $13,099 | $23,337 | $17,807 |
| Shareholders' Equity | |||
| Retained earnings | 1,286 | 2,624 | -5,134 |
| TOTAL | $12,477 | $14,223 | $10,008 |
| Total Liabilities And Equity | $25,576 | $37,561 | $27,816 |